Clinical Advances in
The non-vitamin K antagonist oral anticoagulants (NOACs) have the potential to change the way thromboembolic disorders are treated. The Anticoagulation Management section of this site will highlight clinical data updates in settings of atrial fibrillation and venous thromboembolism where the NOACs are now widely used and discuss application of the latest data in patient care.
NOACs are also being investigated in other disorders, including coronary and peripheral artery disease (CAD/PAD), heart failure, and others. The Vascular Protection section of the site will explore the emerging clinical data for NOACs and discuss new paradigms in thrombotic protection and potential implications for clinical care.
View programs for: Anticoagulation Management Vascular Protection
Supported by
Bayer AG
Steering Committee Chair
Professor of Cardiology
University of Edinburgh
Edinburgh, United Kingdom
Professor
St. George's University of London
London, United Kingdom
Professor
University of Connecticut
Storrs, Connecticut, United States
Professor of Internal Medicine and Vascular Disease
H�pital Saint-Louis, AP-HP
Paris University France
McGill University
Montreal, Quebec, Canada
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
Sondra and Stephen Hardis Chair in Oncology Research
Vice Chair (Clinical Services)
Director
GI Malignancies Program
Taussig Cancer Institute
Cleveland Clinic
Cleveland, Ohio, United States
Assistant Professor of Medicine
Harvard Medical School
Director of General Cardiology
Cardiovascular Division
TIMI Study Group
Brigham and Women's Hospital
Boston, Massachusetts, United States
Professor
University of Leuven
Leuven, Belgium
Steering Committee Chair
Professor of Cardiology
University of Edinburgh
Edinburgh, United Kingdom
Professor
Head of Department of Cardiology
Dupuytren University Hospital
Limoges, France
Professor of Medicine
Harvard Medical School
Executive Director, Interventional Cardiovascular Programs
Brigham and Women's Hospital Heart & Vascular Center
Boston, Massachusetts, United States
Professor
McMaster University
Hamilton, Ontario, Canada
Professor of Medicine
Duke University Medical Center
Durham, North Carolina, United States
Professor of Medicine
University of Alberta in Edmonton
Director of Cardiac Catheterization and Interventional Cardiology
Mazankowski Alberta Heart Institute
Edmonton, Alberta, Canada